Pharmaceutics (Nov 2022)

Synthetic Post-Contrast Imaging through Artificial Intelligence: Clinical Applications of Virtual and Augmented Contrast Media

  • Luca Pasquini,
  • Antonio Napolitano,
  • Matteo Pignatelli,
  • Emanuela Tagliente,
  • Chiara Parrillo,
  • Francesco Nasta,
  • Andrea Romano,
  • Alessandro Bozzao,
  • Alberto Di Napoli

DOI
https://doi.org/10.3390/pharmaceutics14112378
Journal volume & issue
Vol. 14, no. 11
p. 2378

Abstract

Read online

Contrast media are widely diffused in biomedical imaging, due to their relevance in the diagnosis of numerous disorders. However, the risk of adverse reactions, the concern of potential damage to sensitive organs, and the recently described brain deposition of gadolinium salts, limit the use of contrast media in clinical practice. In recent years, the application of artificial intelligence (AI) techniques to biomedical imaging has led to the development of ‘virtual’ and ‘augmented’ contrasts. The idea behind these applications is to generate synthetic post-contrast images through AI computational modeling starting from the information available on other images acquired during the same scan. In these AI models, non-contrast images (virtual contrast) or low-dose post-contrast images (augmented contrast) are used as input data to generate synthetic post-contrast images, which are often undistinguishable from the native ones. In this review, we discuss the most recent advances of AI applications to biomedical imaging relative to synthetic contrast media.

Keywords